[
  {
    "ts": null,
    "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of September 7",
    "summary": "A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read the full article here.",
    "url": "https://finnhub.io/api/news?id=ff914b676260c3d875ed7f5add1e0b873c78fd74eee4f340db91c840588fe9c1",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757099009,
      "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of September 7",
      "id": 136651455,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read the full article here.",
      "url": "https://finnhub.io/api/news?id=ff914b676260c3d875ed7f5add1e0b873c78fd74eee4f340db91c840588fe9c1"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
    "summary": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=3e31781b2df75494a8a03c7c7eb61f0d4b67b9d85e505bbf23b13a3f02a34b7d",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757090160,
      "headline": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
      "id": 136715056,
      "image": "",
      "related": "GILD",
      "source": "MarketWatch",
      "summary": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=3e31781b2df75494a8a03c7c7eb61f0d4b67b9d85e505bbf23b13a3f02a34b7d"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences advances HIV prevention with new US partnership",
    "summary": "Gilead plans to submit regulatory filings for lenacapavir for PrEP in 18 nations.",
    "url": "https://finnhub.io/api/news?id=ce1a22216799863e2f995a1c3a6055a0d3b8f8d9c0b21572c620ec22ee8d925e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757066439,
      "headline": "Gilead Sciences advances HIV prevention with new US partnership",
      "id": 136647885,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead plans to submit regulatory filings for lenacapavir for PrEP in 18 nations.",
      "url": "https://finnhub.io/api/news?id=ce1a22216799863e2f995a1c3a6055a0d3b8f8d9c0b21572c620ec22ee8d925e"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer: Still A Bargain Despite Kennedy's Anti-Vaccine Attacks",
    "summary": "Pfizer Inc.'s strong Q2 2025 sales defy expectations. Discover analyst insights, growth drivers, and why it's rated Strong Buy. Click for my PFE stock update.",
    "url": "https://finnhub.io/api/news?id=d73fe54fc34318ccf1d3729ec1a04d051d9f77957ff3802476624a400c8c850d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757063226,
      "headline": "Pfizer: Still A Bargain Despite Kennedy's Anti-Vaccine Attacks",
      "id": 136647643,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1304540314/image_1304540314.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Pfizer Inc.'s strong Q2 2025 sales defy expectations. Discover analyst insights, growth drivers, and why it's rated Strong Buy. Click for my PFE stock update.",
      "url": "https://finnhub.io/api/news?id=d73fe54fc34318ccf1d3729ec1a04d051d9f77957ff3802476624a400c8c850d"
    }
  }
]